Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 10469432)

1.

Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cells.

Zhou X, Kim SH, Shen L, Lee HJ, Chen C.

Cell Cycle. 2014;13(15):2340-8. doi: 10.4161/cc.29297.

PMID:
25483185
2.

Regulation of the viability of Nf1 deficient cells by PKC isoforms.

Zhou X, Shen L, Parris T, Huang J, Yi B, Helou K, Chen C.

Oncotarget. 2014 Nov 15;5(21):10709-17.

3.

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.

Widemann BC, Dombi E, Gillespie A, Wolters PL, Belasco J, Goldman S, Korf BR, Solomon J, Martin S, Salzer W, Fox E, Patronas N, Kieran MW, Perentesis JP, Reddy A, Wright JJ, Kim A, Steinberg SM, Balis FM.

Neuro Oncol. 2014 May;16(5):707-18. doi: 10.1093/neuonc/nou004. Epub 2014 Feb 4.

4.

Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.

Chau V, Lim SK, Mo W, Liu C, Patel AJ, McKay RM, Wei S, Posner BA, De Brabander JK, Williams NS, Parada LF, Le LQ.

Cancer Res. 2014 Jan 15;74(2):586-97. doi: 10.1158/0008-5472.CAN-13-1934. Epub 2013 Nov 27.

5.

MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N.

J Clin Invest. 2013 Jan;123(1):340-7. doi: 10.1172/JCI60578. Epub 2012 Dec 10.

6.

Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.

Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B.

J Pediatr Psychol. 2012 Aug;37(7):713-24. doi: 10.1093/jpepsy/jsr124. Epub 2012 Feb 21.

7.

Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.

Wu J, Dombi E, Jousma E, Scott Dunn R, Lindquist D, Schnell BM, Kim MO, Kim A, Widemann BC, Cripe TP, Ratner N.

Pediatr Blood Cancer. 2012 Feb;58(2):173-80. doi: 10.1002/pbc.23015. Epub 2011 Feb 11.

8.

Genetic aspects of cerebrovascular malformations.

Shovlin CL.

Interv Neuroradiol. 2000 Jun 30;6(2):107-11. Epub 2001 May 15.

9.

Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Shilyansky C, Lee YS, Silva AJ.

Annu Rev Neurosci. 2010;33:221-43. doi: 10.1146/annurev-neuro-060909-153215. Review.

10.

Ral overactivation in malignant peripheral nerve sheath tumors.

Bodempudi V, Yamoutpoor F, Pan W, Dudek AZ, Esfandyari T, Piedra M, Babovick-Vuksanovic D, Woo RA, Mautner VF, Kluwe L, Clapp DW, De Vries GH, Thomas SL, Kurtz A, Parada LF, Farassati F.

Mol Cell Biol. 2009 Jul;29(14):3964-74. doi: 10.1128/MCB.01153-08. Epub 2009 May 4.

11.

Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.

Macy ME, Sawczyn KK, Garrington TP, Graham DK, Gore L.

Curr Oncol Rep. 2008 Nov;10(6):477-90. Review.

12.

Alphavirus production is inhibited in neurofibromin 1-deficient cells through activated RAS signalling.

Kolokoltsova OA, Domina AM, Kolokoltsov AA, Davey RA, Weaver SC, Watowich SJ.

Virology. 2008 Jul 20;377(1):133-42. doi: 10.1016/j.virol.2008.03.025. Epub 2008 May 15.

13.

Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.

Le LQ, Parada LF.

Oncogene. 2007 Jul 12;26(32):4609-16. Epub 2007 Feb 12. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk